Regarding limitations of single mTOR or PI3K targeting in AML cells, it has been previously demonstrated that mTOR inhibition leads to activation of PI3K signaling via upregulation of IGF-1 [35]. Here, PIK3CD is linked to acute myeloid leukemia.